{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-046716","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-03-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.124435+00:00","generated_at":"2026-05-24T03:14:32.588989+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"HCW Biologics reports FY2024 net loss $30M; going concern doubt, plans financing","bullets":["FY2024 revenue $2.6M (vs $2.8M); net loss $30.0M (vs $25.0M); legal expenses $15.9M from arbitration.","Q4 2024 revenue $394,804 (vs $1.3M); net loss $3.4M (vs $10.7M).","Substantial doubt about going concern; financing plan includes $20M equity line with Square Gate and $7M milestone from WY Biotech license.","Nasdaq extension to April 28 (bid price) and June 15 (other rules); special meeting March 31 for reverse split and conversions.","IND cleared for HCW9302 Phase 1 in alopecia areata; Phase 2 ovarian cancer study closed due to poor enrollment."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-046716","json":"https://secwatch.observer/filing/0000950170-25-046716.json","markdown":"https://secwatch.observer/filing/0000950170-25-046716.md","text":"https://secwatch.observer/filing/0000950170-25-046716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025046716/0000950170-25-046716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025046716/hcwb-20250328.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T03:14:32.588989+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}